WSP

0.00%

55.0¢ whispir limited

Ann: Investor Presentation - FY23 Results, page-57

First 57 Last

Share
Profile

Follow
Quest09

767 Posts.

104

26/09/23

15:43

Post #: 70034433
Share
Originally posted by Quest09: ↑

Expand

Originally posted by Quest09: ↑

IMO, one the more interesting and promising aspects of WSPs customers base is the diverse source of their clients. WSP has displayed an ability to secure customers from the Govt Sector and from Private/Public Companies. Within both of these categories, clients are sourced from a wide range of industry sectors.

IMO, it shows that there is a lot of potential growth for WSP, as almost every type of business/organisation has a use for WSPs product.

Expand

Originally posted by Quest09: ↑

WSP new product line for FY24

Two products due to be released during THIS coming quarter, FY24 Q1:

1) Whispir Verify

2) Content AI

Only 4 weeks left in this first quarter. Market Announcements about these products could be released at any moment.

Four more products due for release during this financial year.

Expand

Originally posted by Quest09: ↑

Expand

Originally posted by Quest09: ↑

WSP FY24 Outlook and Path to Profitability

Positive free cash flow driven by strengthened operating leverage and planned revenue growth:
Execution of the product road map – delivering four new major releases
Revenue growth largely driven by existing install-base increasing usage
Continued improvement in gross margins, driven by more favourable wholesale pricing recently obtained from Telco carriers
Cost base to remain capped at $36m
Generating free cash flow from 2H FY24 onwards.

Expand

Originally posted by Quest09: ↑

Fundamentals still remain strong IMO.

$53 million in revenue for the year. Increased gross profit margin to 62% GP. Asia revenue growth at 19% to $8 million.

Market cap currently about $40 Million.

Significantly underpriced IMO.

Expand

Originally posted by Quest09: ↑

WSP delivering as promised with the release of 4 new products, including AI based technology.

More products are scheduled for release during the coming financial year.

Expand

Originally posted by Quest09: ↑

WSP looks like good buying at this currently reduced price IMO.

WSP recently announced annual revenue of $53 million dollars with a 62% gross profit margin. Asia revenue growth at 19% to $8 million.

Also announced a forecast for growth and a cash positive position in the coming financial year. Openly stated that they will not need a cap raise in the coming year.

Current market cap is only ~$38 million.

Expand

Happy to back my statements and position. Ultimately, time will tell..
WSP Price at posting: 31.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

First 57 Last

Add WSP (ASX) to my watchlist

Ann: Investor Presentation - FY23 Results, page-57

Featured News

Daily ASX Market Update: Health pushes shares into gain terrain - May 31, 2024

The $ and the sense: Andrew Demetriou talks through sports deals that shaped AFL

Little Green Pharma's cannabis sales leap 30%

Talga shows expansion options for Sweden's Vittangi graphite project

Making the best of an inflationary environment

Thor reports 200% increase in tungsten at NT's Molyhil

Daily ASX Market Close: Late run sees market lift 1%, May 31, 2024

Spacetalk makes European Market Reentry with Elisa

Telix testing shows efficacy of anti-prostate cancer therapy

Peak shale oil and fracking activity drives demand for Eden's Optiblend in the USA

Ann: Investor Presentation - FY23 Results, page-57

Featured News

Top Stories

Daily ASX Market Update: Health pushes shares into gain terrain - May 31, 2024

The $ and the sense: Andrew Demetriou talks through sports deals that shaped AFL

Little Green Pharma's cannabis sales leap 30%

Talga shows expansion options for Sweden's Vittangi graphite project

Making the best of an inflationary environment

Thor reports 200% increase in tungsten at NT's Molyhil

Daily ASX Market Close: Late run sees market lift 1%, May 31, 2024

Spacetalk makes European Market Reentry with Elisa

Telix testing shows efficacy of anti-prostate cancer therapy

Peak shale oil and fracking activity drives demand for Eden's Optiblend in the USA